Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Sees Significant Decline in Short Interest

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the recipient of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 500 shares, a decrease of 28.6% from the October 31st total of 700 shares. Based on an average trading volume of 12,800 shares, the days-to-cover ratio is presently 0.0 days.

Relief Therapeutics Price Performance

Shares of RLFTF traded up $0.02 during trading hours on Friday, hitting $5.60. The company had a trading volume of 327 shares, compared to its average volume of 2,846. The business has a fifty day moving average of $5.64 and a 200-day moving average of $2.94. Relief Therapeutics has a 12 month low of $1.10 and a 12 month high of $7.66.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.